Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Prostate Cancer

13 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Diagnostic

    VICCURO15140

    01/18/2016

    Analysis of Cell-Free DNA (cfDNA) in Men with Elevated PSA Levels

    Health Services Research

    VICCURO1589

    03/16/2016

    A Prospective Observational Cohort Study of Patients with Castration- Resistant Prostate Cancer (CRPC) in the United States

    Health Services Research

    VICCURO1638

    06/29/2015

    Patient-Centered Treatment Decision-Making in Advanced Prostate Cancer

    Other

    VICCURO16112

    10/25/2016

    Prospective Observational Trial of an Absorbable Hydrogel Spacer in Prostate Cancer Radiotherapy

    Other

    URO70807-M

    05/10/2012

    Men's Eating and Living Study: A Randomized trial of diet to alter disease progression in prostste cancer patients on active surveillance

    Supportive Care

    VICCURO16133

    03/31/2017

    Cognitive Effects of Androgen Receptor (AR) Directed Therapies for Advanced Prostate Cancer

    Treatment

    VICCURO1677

    08/09/2016

    Evaluation of the TULSA-PRO MRI-Guided Transurethral Ultrasound Prostate Ablation Device in Patients with Localized Prostate Cancer: a Prospective, Single-Arm, Pivotal Clinical Study

    Treatment

    NRGUROR0924

    03/10/2016

    Androgen Deprivation Therapy and High Dose Radiotherapy with or without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial

    Treatment

    VICCURO1540

    07/08/2015

    A Phase 3, Randomized, Efficacy and Safety Study of Enzalutamide Plus Leuprolide, Enzalutamide Monotherapy, and Placebo Plus Leuprolide in Men with High-Risk Nonmetastatic Prostate Cancer Progressing After Definitive Therapy. MDV3100-13

    Treatment

    CTSUALLIANCEURO031201-M

    11/21/2014

    URO A031201: Phase III Trial of Enzalutamide (NSC # 766085) Versus Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer

    Treatment

    VICCURO1450

    08/13/2014

    PROSPER: A Multinational, Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Enzalutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer

    Treatment

    CTSUUROS1216-M

    01/16/2014

    A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 with Androgen Deprivation Therapy + Bicalutamide in Patients with Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer

    Treatment

    CTSUUROC90203-M

    11/05/2007

    A randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Prostatectomy Versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer


    Print this page for your doctor